mhra

MHRA expands application information for London regulatory sandbox

MHRA has added information on the next application stage for its London sandbox, including what happens after expressions of interest have been screened.

Ersin ÇETİNMDR Auditor
Türkçe oku
Conceptual illustration of AI-enabled medical devices connected to a London healthcare network within a regulatory sandbox
AI-generated conceptual illustration, not a photograph of an actual event.

What Changed

The Medicines and Healthcare products Regulatory Agency (MHRA) revised its London Region I MHRA Regulatory Sandbox call for expressions of interest on 18 November 2026. The guidance now includes information on the next application stage, including what happens after expressions of interest have been screened.

The call concerns participation in an initiative exploring the safe and responsible deployment of innovative technologies in real-world healthcare settings in London.

Who Is Affected

The invitation is directed at AI-enabled medical device manufacturers and NHS provider organisations interested in participating. The sandbox will bring together manufacturers, NHS organisations and regulatory experts.

Separate expression-of-interest forms are available for manufacturers and providers.

Regulatory and Technical Implications

The sandbox’s stated focus is safe and responsible deployment in healthcare practice. MHRA describes a collaborative setting involving technology developers, healthcare organisations and regulatory expertise.

The 18 November revision concerns the application pathway. The publication’s change record identifies post-screening information as the addition; applicants should consult the HTML guidance for the detailed next-stage arrangements.

Manufacturer Actions

Interested manufacturers can consult the HTML guidance and the manufacturer expression-of-interest form. The manufacturer form is listed as an 84.3 KB Word document, while the provider form is 82.5 KB.

MHRA warns that these files may not be suitable for assistive-technology users. Accessible versions can be requested at webupdates@mhra.gov.uk, specifying the required format and, where possible, the assistive technology used.

Confirmed Dates

The sandbox was announced in June 2026. The call was first published on 30 July 2026, and the next-stage application information was added on 18 November 2026.

The publication page does not specify an application deadline.

Official Source

MHRA’s GOV.UK publication, “London Region I MHRA Regulatory Sandbox: call for expressions of interest”, contains the HTML guidance and both expression-of-interest forms.

Https://www.gov.uk/government/publications/london-region-i-mhra-regulatory-sandbox-call-for-expressions-of-interest

Source and related services

Guidance: London Region I MHRA Regulatory Sandbox: call for expressions of interest ↗

Source date: 18/11/2026

This news provides general information and does not replace device-specific legal or conformity assessment advice.

Related news

UK backs modernisation of gene therapy definitions →MHRA records closure of an IDAP UCNA entry →MHRA appoints Steven Davies to lead finance and commercial operations →
Contact an MDR Expert